Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
Researchers are trying to assess the appropriate dose of estrogen for decreasing the risk of
cardiovascular disease in women who have removal of their ovaries at a young age, before the
age of 46 years.